Cargando…

Use of levosimendan in acute and advanced heart failure: short review on available real-world data

Published data have shown potential advantages of levosimendan in the management of acute decompensated heart failure and advanced heart failure when standard medical therapies threaten hemodynamics and organ perfusion are unable to alleviate clinical symptoms. Levosimendan distinguishes itself from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pashkovetsky, Eugene, Gupta, Chhaya Aggarwal, Aronow, Wilbert S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588712/ https://www.ncbi.nlm.nih.gov/pubmed/31354283 http://dx.doi.org/10.2147/TCRM.S188761

Ejemplares similares

Intermittent levosimendan infusions in advanced heart failure: a real world experience
por: Ortis, Benedetta, et al.
Publicado: (2017)

Repetitive levosimendan treatment in the management of advanced heart failure
por: Oliva, Fabrizio, et al.
Publicado: (2018)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure
por: Delgado, Juan F., et al.
Publicado: (2017)

Haemodynamic effects of levosimendan in advanced but stable chronic heart failure
por: Najjar, Emil, et al.
Publicado: (2018)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Levosimendan improves exercise performance in patients with advanced chronic heart failure
por: Mushtaq, Saima, et al.
Publicado: (2015)

The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
por: Nieminen, Markku S., et al.
Publicado: (2017)

Levosimendan in acute and advanced heart failure: still some chapters to be written
por: Pölzl, Gerhard
Publicado: (2018)

A review of levosimendan in the treatment of heart failure
por: Kasikcioglu, Hulya Akhan, et al.
Publicado: (2006)

Levosimendan in pulmonary hypertension and right heart failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)

Ambulatory pulmonary artery pressure monitoring in advanced heart failure patients
por: Yandrapalli, Srikanth, et al.
Publicado: (2017)

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
por: Bouchez, S., et al.
Publicado: (2018)

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019)

Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients
por: Milwidsky, Assi, et al.
Publicado: (2022)

Therapeutic Development of Levosimendan in Acute and Advanced Heart Failure: A Systematic Review
por: Desai, Heet N, et al.
Publicado: (2023)

Pulsed Levosimendan in advanced heart failure due to congenital heart disease: a case series
por: Cranley, James, et al.
Publicado: (2020)

Update of treatment of heart failure with reduction of left ventricular ejection fraction
por: Aronow, Wilbert S.
Publicado: (2016)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Use of Inotropic Agents in Treatment of Systolic Heart Failure
por: Tariq, Sohaib, et al.
Publicado: (2015)

Impact of levosimendan on efficacy and renal function in acute heart failure according to renal function: A perspective, multi-center, real-world registry
por: Zhang, Han, et al.
Publicado: (2022)

Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure
por: Lilleberg, J, et al.
Publicado: (2002)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure
por: Tasal, Abdurrahman, et al.
Publicado: (2014)

Levosimendan in Acute and Advanced Heart Failure: An Appraisal of the Clinical Database and Evaluation of Its Therapeutic Applications
por: Altenberger, Johann, et al.
Publicado: (2018)

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post‐discharge period
por: Pölzl, Gerhard, et al.
Publicado: (2018)

Efficacy and safety of intermittent repeated levosimendan infusions in advanced heart failure patients: the LAICA study
por: García‐González, Martín J., et al.
Publicado: (2021)

Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry
por: Dobarro, David, et al.
Publicado: (2023)

Echocardiography and impedance cardiography as determinants of successful slow levosimendan infusion in advanced older heart failure patients
por: Ruocco, Gaetano, et al.
Publicado: (2021)

Efficiency and Safety of Prolonged Levosimendan Infusion in Patients with Acute Heart Failure
por: Aidonidis, Georgios, et al.
Publicado: (2011)

Retrospective study of proarrhythmic effects of levosimendan during the therapy of heart failure
por: Zima, E, et al.
Publicado: (2007)

Preoperative optimization with levosimendan in heart failure patient undergoing thoracic surgery
por: Nespoli, Moana Rossella, et al.
Publicado: (2016)

The inodilator levosimendan as a treatment for acute heart failure in various settings
por: Gustafsson, Finn, et al.
Publicado: (2017)

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Effects of Levosimendan on cardiac function, size and strain in heart failure patients
por: Beitzke, D., et al.
Publicado: (2020)

Levosimendan in the modern treatment of patients with acute heart failure of various aetiologies
por: Glinka, Lidia, et al.
Publicado: (2019)

Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap
por: Conti, Nicolina, et al.
Publicado: (2021)

Mortality reduction with levosimendan in patients with heart failure: Current evidence is underpowered
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Impact of Sacubitril/Valsartan on Patient Outcomes in Heart Failure: Evidence to Date
por: Akbar, Sara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_54h4ril42gj9ua6t53cb5uti3v